6IC NewsOriginal AI Journalism ← All news
⚙️ Technology

PCSK9

1 story First seen Jul 17, 2026 Latest Jul 17, 2026
🧬 AI profile — grown from 6ic coverage PCSK9, or Proprotein Convertase Subtilisin/Kexin Type 9, is a protein involved in the regulation of cholesterol levels in the blood. It plays a key role in the liver's ability to remove low-density lipoprotein (LDL) cholesterol, also known as "bad" cholesterol, from the bloodstream. The development of PCSK9 inhibitors has led to breakthroughs in cholesterol treatment, offering an alternative to statins for patients with high cholesterol.

Coverage by desk

Health 1

Coverage · last 14 days

Jul 4Jul 17

Recurring themes

🕸 Connection map 🌌 Full galaxy →

Connected entities

Every story (1)

Breakthrough in Cholesterol Treatment: FDA Approves New Alternative to Statins
Health · Jul 17, 2026 · Legacy Media Killer AI